Tenderwize
Back to tender search

Open-House Biologics Discount Contracts 2024-11 - Hepatitis B Immune Globulin (ATC Code J06BB04)

Techniker Krankenkasse·Hamburg, Germany·Deadline Oct 29, 2026 · 72 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2024-11 - Hepatitis-B-Immunglobulin (ATC-Code J06BB04)

50/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

40 / 100

Risk factors

No commitment from health insurers to purchase any quantity; actual uptake depends on pharmacy selections.

Subject to dispute resolution via social courts, not procurement chambers; legal uncertainty if classification as publi...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Oct 2026
  • Conclusion of discount contracts for Hepatitis-B immune globulin (ATC J06BB04) with qualified pharmaceutical entrepreneurs
  • Open-house procedure with no exclusivity and no negotiation of terms
Show full summary

Open-house procedure by German health insurers (Techniker Krankenkasse, HEK, hkk) to conclude discount contracts for Hepatitis-B immune globulin (ATC J06BB04) under §130a Abs. 8 SGB V. The procedure runs from 01.11.2024 to 31.10.2026, with eligibility for any qualified pharmaceutical entrepreneur meeting authorization and reliability criteria. Contracts are non-exclusive, no negotiations, and participation possible at any time during the term. No estimated value provided.

Risks

No commitment from health insurers to purchase any quantity; actual uptake depends on pharmacy selections.

Subject to dispute resolution via social courts, not procurement chambers; legal uncertainty if classification as publi...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur according to §4 Abs. 18 AMG regarding the offered medicinal product
  • Must have a valid marketing authorization under §21 AMG or equivalent right to place on the market
  • Must have seat in Germany, EU, or EEA (§9 Abs. 2 AMG)

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House Biologics Discount Contracts 2024-11 - Hepatitis B Immune Globulin (ATC Code J06BB04)

Conclusion of discount contracts for Hepatitis-B immune globulin (ATC J06BB04) as an open-house procedure. No exclusivity, no negotiations, uniform conditions.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Oct 2024 - Oct 2026

Category

Pharmaceutical products

Deadline

Deadline Oct 29, 2026

Procurement Details

Publication date
22 Sep 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
569809-2024

Documents (1)

Similar tenders